Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/1995
08/29/1995US5445932 Presence of anti-HDAg'antibodies predicts shortened lifespan of patient
08/29/1995US5445820 Streptolysin O peptide antigens and methods for the determination of streptolysin antibodies
08/29/1995US5445818 Synthetic pseudomonas aeruginosa pilin peptide vaccine and method of use
08/29/1995CA2059840C Composition for the treatment of diabetes
08/29/1995CA1336855C Protein curculin and application of the same
08/29/1995CA1336827C 8-hydroxyquinoline chelating agents
08/29/1995CA1336826C Chimeric antibody with specificity to human b cell surface antigen
08/29/1995CA1336817C Angiogenesis inhibitor
08/29/1995CA1336813C Urogenital sinus derived growth inhibitory factor
08/29/1995CA1336812C Human collagen processing and autoimplant use
08/25/1995CA2143261A1 Method of diagnosing cancer, precancerous state, or susceptibility to other forms of diseases by analysis of irf-1-specific rna in biopsy samples
08/24/1995WO1995022625A1 Dna mutagenesis by random fragmentation and reassembly
08/24/1995WO1995022619A1 B7-1-specific ligands, and their use for the induction of t cell anergy
08/24/1995WO1995022618A1 Nucleic acid delivery system, method of synthesis and uses thereof
08/24/1995WO1995022616A1 Animal model of the alzheimer disease, preparation and utilisations
08/24/1995WO1995022614A1 Production of glycosylphosphatidylinositol-anchored recombinant proteins
08/24/1995WO1995022612A2 Genes and genetic elements associated with sensitivity to platinum-based drugs
08/24/1995WO1995022611A2 Methods and compositions for stimulating bone cells
08/24/1995WO1995022610A1 Novel integrin alpha subunit
08/24/1995WO1995022609A2 Human glutamate receptor proteins
08/24/1995WO1995022608A1 Galanin receptor, nucleic acids, transformed cells and uses thereof
08/24/1995WO1995022607A1 Recombinant equine herpesviruses
08/24/1995WO1995022604A1 Rna editing enzyme and methods of use thereof
08/24/1995WO1995022603A1 Vaccine to control ectoparasites
08/24/1995WO1995022561A2 Peptides recognized by melanoma-specific cytotoxic lymphocytes, and uses therefor
08/24/1995WO1995022560A1 Pharmaceutical formulations of cntf
08/24/1995WO1995022559A1 Immunosuppressive compounds and method of preparing same
08/24/1995WO1995022556A1 Process for removing endotoxins
08/24/1995WO1995022349A1 Verotoxin pharmaceutical compositions and medical treatments therewith
08/24/1995WO1995022346A1 Use of ceruletide diethyl amine salt in the treatment of psoriasis
08/24/1995WO1995022344A1 Therapeutic use of myelin-associated glycoprotein (mag)
08/24/1995WO1995022340A1 Methods for altering fertility
08/24/1995WO1995022317A1 Compositions and methods for eliciting ctl immunity
08/24/1995WO1995022258A2 Isolation of lactoferrin from milk
08/24/1995WO1995022249A1 Transgenic fibrinogen
08/24/1995WO1995019435A3 T cell antigen receptor v region proteins and methods of preparation thereof
08/24/1995WO1995013374A3 Human and mouse very low density lipoprotein receptors and methods for use of such receptors
08/24/1995CA2183680A1 B7-1-specific ligands, and their use for the induction of t cell anergy
08/24/1995CA2183667A1 Nucleic acid delivery system, method of synthesis and uses thereof
08/24/1995CA2183630A1 Therapeutic use of myelin-associated glycoprotein (mag)
08/24/1995CA2183459A1 Isolation of lactoferrin from milk
08/24/1995CA2183416A1 Compositions and methods for eliciting ctl immunity
08/24/1995CA2183253A1 Rna editing enzyme and methods of use thereof
08/24/1995CA2183157A1 Immunosuppressive compounds and method of preparing same
08/24/1995CA2182880A1 Recombinant equine herpesviruses
08/24/1995CA2182724A1 Animal model of the alzheimer disease, preparation and utilisations
08/24/1995CA2160251A1 Use of ceruletide diethyl amine salt in the treatment of psoriasis
08/24/1995CA2159995A1 Process for removing endotoxins
08/23/1995EP0668358A1 Antibiotic WAP-8294A, method for preparing the same and antibacterial composition
08/23/1995EP0668357A1 Vector for integration site independent gene expression in mammalian host cells
08/23/1995EP0668356A2 Recombinant infectious bovine rhinotracheitis virus mutant, methods for the production of same, and vaccines containing the same
08/23/1995EP0668355A1 Vaccine for the protection of horses against equine herpesvirus infection
08/23/1995EP0668354A1 Cysteine added variants of G-CSF and chemical modifications thereof
08/23/1995EP0668353A1 Cysteine added variants of EPO and chemical modifications thereof
08/23/1995EP0668352A1 Protein having TPO activity
08/23/1995EP0668351A1 Erythropoietin isoforms
08/23/1995EP0668350A1 Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma
08/23/1995EP0668292A2 Process to obtain insulin with correct cystin bridges
08/23/1995EP0668291A2 Mammalian augmenter of liver regenerating and variants thereof
08/23/1995EP0668290A1 Physiologically active substance well capable of permeating biomembrane
08/23/1995EP0668077A1 Compositions containing G-CSF and TNF binding protein
08/23/1995EP0667959A1 METHODS AND COMPOSITIONS FOR THE DETECTION OF SOLUBLE $g(b)-AMYLOID PEPTIDE
08/23/1995EP0667917A1 Evolutive vaccination.
08/23/1995EP0667916A1 Crf binding protein
08/23/1995EP0667912A1 Defective adenovirus vectors and use thereof in gene therapy
08/23/1995EP0667909A1 Biotechnological method of producing biotin
08/23/1995EP0667908A1 Soluble t-cell receptor alpha chain and derivatives used as prophylactic and therapeutic agents for autoimmune diseases
08/23/1995EP0667905A1 Antifungal chitin binding proteins and dna coding therefor
08/23/1995EP0667904A1 Suppressor and progenitor cells
08/23/1995EP0667903A1 Recombinant human erythropoietin with altered biological activity
08/23/1995EP0667902A1 Cdr grafted humanised chimeric t-cell antibodies
08/23/1995EP0667901A1 Novel cytokine
08/23/1995EP0667900A1 Introns and exons of the cystic fibrosis gene and mutations at various positions of the gene
08/23/1995EP0667899A1 Mutated growth factor receptor as medicament and its use for treating cancer
08/23/1995EP0667896A1 Direct selection of cells by secretion product
08/23/1995EP0667872A1 Mutant interleukin 6 with improved biological activity over wild interleukin 6
08/23/1995EP0667871A1 Biologically active amphiphilic peptide compositions and uses therefor
08/23/1995EP0667870A1 COMPOSITIONS AND METHODS FOR MODIFYING THE REGULATORY ACTIVITY OF TGF-$g(b)
08/23/1995EP0667792A1 Specific tolerance in transplantation
08/23/1995EP0667790A1 Regulation of cellular invasiveness
08/23/1995EP0667789A1 Restoration of immunocompetency to t helper cells in hiv infected patients
08/23/1995EP0667788A1 Allergenic extracts
08/23/1995EP0667787A1 Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines
08/23/1995EP0667786A1 Retro-, inverso-, and retro-inverso synthetic peptide analogues
08/23/1995EP0667785A1 Method of treating non-streptococcal bacterial infections
08/23/1995EP0667784A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring
08/23/1995EP0667782A1 Reconstituted platelet membrane vesicles
08/23/1995EP0667781A1 Peptide diagnostics and therapeutics for spondyloarthropathies
08/23/1995EP0522010B1 Bcrf1 antagonists for treating epstein-barr virus infections
08/23/1995EP0500576B1 Outer membrane protein p1 and peptides of haemophilus influenzae type b
08/23/1995EP0494929B1 Mutants of the human plasminogen activator inhibitor 1 (pai-1), their preparation and use
08/23/1995EP0110955B1 Brain-specific drug delivery
08/23/1995CN1107159A Linear adhesion inhibitors
08/22/1995US5444167 Variant luteinizing hormone encoding DNA
08/22/1995US5444166 Constitutive triple response gene and mutations
08/22/1995US5444164 TGF-β induced gene
08/22/1995US5444159 Purification of a pertussis outer membrane protein
08/22/1995US5444158 Merosin, nucleic acids encoding, fragments and uses thereof
08/22/1995US5444157 Stimulates growth of chondrocytes and/or inhibits growth of tumors
08/22/1995US5444154 Crosslinked protein polymers as humectants
1 ... 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 2597 2598 2599 2600 2601 2602 2603 2604 2605 ... 2916